A Multi-Centre COVID-19 Study Examining Symptoms and Medication Use in the Final Week of Life
CONCLUSION: Symptoms peaked in final 3 days of life. Earlier use of infusional and breakthrough medications should be considered in anticipation of symptoms given high likelihood of dying in discomfort. Earlier palliative care referral for high-risk patients should be considered at hospital admission.PMID:35644508 | PMC:PMC9134756 | DOI:10.1016/j.jpainsymman.2022.05.013
Source: Pain Physician - Category: Anesthesiology Authors: Aaron K Wong Olivia Wawryk Michael G Sabe Jaclyn Yoong Rachel Everitt Ruwani Mendis Joyce Chua Maria Pisasale Brian Le Source Type: research
More News: Anesthesiology | Australia Health | COVID-19 | Men | Pain | Pain Management | Palliative | Palliative Care | Respiratory Medicine | Study